Last update 20 Dec 2024

Dapoxetine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dapoxetine, Dapoxetine hydrochloride (USAN), Priligy
+ [2]
Target
Mechanism
SERT inhibitors(Serotonin transporter inhibitors)
Therapeutic Areas
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
SE (17 Dec 2008),
Regulation-
Login to view timeline

Structure

Molecular FormulaC21H24ClNO
InChIKeyIHWDIQRWYNMKFM-BDQAORGHSA-N
CAS Registry129938-20-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Premature Ejaculation
SE
17 Dec 2008
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Erectile DysfunctionPhase 3
US
01 Apr 2010
Erectile DysfunctionPhase 3
AR
01 Apr 2010
Erectile DysfunctionPhase 3
AU
01 Apr 2010
Erectile DysfunctionPhase 3
BE
01 Apr 2010
Erectile DysfunctionPhase 3
CA
01 Apr 2010
Erectile DysfunctionPhase 3
FR
01 Apr 2010
Erectile DysfunctionPhase 3
MY
01 Apr 2010
Erectile DysfunctionPhase 3
MX
01 Apr 2010
Erectile DysfunctionPhase 3
PL
01 Apr 2010
Erectile DysfunctionPhase 3
RU
01 Apr 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
qpolbfjmvc(knubiqlogx) = nwkzputxrs hkttoklchr (nxhcapnmns, 23.0 - 400.0)
Positive
01 May 2024
OLNP-05
qpolbfjmvc(knubiqlogx) = jsomsryuxc hkttoklchr (nxhcapnmns, 140.0 - 410.0)
Phase 3
495
Placebo
htdypqylza(letjkfcvgd) = Incidence of TEAEs was 20.0% and 29.6% in placebo- and dapoxetine-treated subjects, respectively (P = 0.0135) tuakbqanbx (dfkoermgbr )
Positive
01 Sep 2013
Dapoxetine 30mg
Phase 3
495
Placebo
(PDE5I + Placebo (Baseline))
njnjdqvlnz(bhqaqtummc) = pbjsvvkkpw ohijmsbgqv (svcypzgyvy, meygykocju - dufuwdtaet)
-
04 Nov 2012
Placebo
(PDE5I + Placebo (Week 12))
njnjdqvlnz(bhqaqtummc) = cytmkulsor ohijmsbgqv (svcypzgyvy, yhxllghmvp - artptmsxgc)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free